Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Anti-Aging creams put to the test: can they really improve skin longevity?

NCT ID NCT07118943

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested four topical face care products to see if they could improve facial skin longevity over eight weeks. 132 healthy adults aged 40 to 65 used the products twice daily. Researchers measured skin wrinkles with 3D imaging and asked participants about product acceptance through questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
topical face care products (creams or serum)
What this could lead to
If successful, these products could reduce visible wrinkles and improve skin appearance, offering a non-invasive option for skin aging.
What could go wrong
This is a small, completed study with no phase designation, so results may not be generalizable. The primary outcome is product acceptance, not clinical effectiveness, and any benefits may be modest or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

132 people

The number who actually took part.

Started

Aug 2025

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy female and male volunteers aged 40 to 65 years with no signs of skin disorders. * Subject is willing and able to read, understand, and provide written Informed Consent and signed photo release. * Subject has a score of 3.0 to 6.0 for clinically graded visible facial wrinkles using the Fitzpatrick Classification of Facial Wrinkling scale at Baseline, to determine eligibility for the creams or serum test articles or 3.0 to 6.0 for clinically graded visible wrinkles in the eye area using a wrinkling scale for the eye cream test article. * Subject is willing to refrain from applying/using moisturizer, creams, serums or treatment/anti-aging products to their face during the three days prior to Visit 1 (Baseline). Subject's other regular skin products such as cleanser, sunscreen and cosmetics are acceptable. * Subject is willing to come to the test facility with a clean face free of makeup and sunscreen prior to all visits. * Subject is a regular sunscreen user (uses at least 2 times a week). * Subject is willing to avoid direct sun exposure and/or to apply sunscreen to their face in the event of sun exposure. * Subject agrees to remove jewelry and false eye lashes before the visits. * Subject agrees not to introduce any new personal care products or cosmetics to the face while participating on the study. * Subject is willing to avoid use of tanning beds and any use of sunless tanners on the face throughout the study. * Subject is willing to follow study instructions and available to attend all the study visits. * Male only: Male subjects are willing to come to all visits with a clean-shaven face. Goatee and/or mustache are acceptable. Exclusion Criteria: * Female only: Pregnant or lactating or planning a pregnancy during the course of the study. (self-reported). * Piercing or tattoos including permanent or semi-permanent make-up on the face which may interfere with study assessments. * Any conditions on the face that would interfere with evaluations (i.e. full beard, scars, open cuts, sunburn, severe hyperpigmentation, facial hair/peach fuzz, etc.) or active acne or acne marks. * Any skin conditions such as rosacea, eczema, psoriasis, seborrheic dermatitis, vitiligo, etc., or is under the treatment of a doctor for any skin condition on the face. * Use of a self-tanner/stain on the face within two weeks of the study start. * Allergies or sensitivities to facial moisturizer products, similar materials or their ingredients or cosmetics. * Insulin-dependent diabetes. * Hematological or immune deficiency disease such as HIV positive, AIDS, Systemic Lupus Erythematosus. * Recent use within the last 14 days of a chemical peel or is currently using an in-home or professional chemical peel on their facial skin. * Subject has had a cosmetic medical procedure in the test area such as injectable anti-wrinkle products (e.g. Botox), facial cosmetic surgery, etc. in the last year. * Current use of OTC (over the counter) pain medication ingested in quantities exceeding label use. * Use of topical treatments such as OTC (over-the-counter) acne medication, hydroquinone, or hydrocortisone on the face in the last month. * Currently participating in another clinical study or trial involving the face. * Subject has been diagnosed with any type of cancer especially skin cancer within the past 12 months or treated for cancer in the last 5 years. * Subject has any medical condition which, in the opinion of the Investigator, would compromise the safety of the subject or confound study results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Princeton Consumer Research Corp.

    Winnipeg, Manitoba, R3L 0J4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.